APA (7th ed.) Citation

Bhagavathula, A. S., Woolf, B., Rahmani, J., Vidyasagar, K., & Tesfaye, W. (2022). Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma. European Journal of Clinical Pharmacology, 78(4), 547. https://doi.org/10.1007/s00228-021-03264-0

Chicago Style (17th ed.) Citation

Bhagavathula, Akshaya Srikanth, Benjamin Woolf, Jamal Rahmani, Kota Vidyasagar, and Wubshet Tesfaye. "Selective Serotonin Reuptake Inhibitor Use and the Risk of Hepatocellular Carcinoma." European Journal of Clinical Pharmacology 78, no. 4 (2022): 547. https://doi.org/10.1007/s00228-021-03264-0.

MLA (9th ed.) Citation

Bhagavathula, Akshaya Srikanth, et al. "Selective Serotonin Reuptake Inhibitor Use and the Risk of Hepatocellular Carcinoma." European Journal of Clinical Pharmacology, vol. 78, no. 4, 2022, p. 547, https://doi.org/10.1007/s00228-021-03264-0.